ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

MGRX vs CCEL // DIVIDEND YIELD & FCF PAYOUT SAFETY

Mangoceuticals Inc. (NASDAQ) VS. Cryo-Cell International Inc. (NYSE) • 15-METRIC TALLY: MGRX 0 — CCEL 4
▲ DIVIDEND YIELD & FCF PAYOUT SAFETY LEADER: CCEL
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MGRX VS. CCEL) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC MGRX CCEL SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 54.90% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 18.20% -53.20 CCEL /roic <GO>
EV/EBITDA & P/E Valuation — 61.2x — TIE /valuation <GO>
Free Cash Flow Yield — 12.55% — TIE /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) -26.00% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety ACTIVE 0.00% 7.73% -7.73 CCEL /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 3/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 32.1 64.3 -32.22 CCEL /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $5.7M $41.8M -$36.2M CCEL /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR MGRX REV CCEL REV MGRX GROSS % CCEL GROSS % MGRX FCF CCEL FCF
FY 2025 $456.0K $0 54.9% — -$5.9M $5.2M
FY 2024 $615.9K $0 61.7% — -$4.9M $3.6M
FY 2023 $731.5K $0 — — -$7.0M $8.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MGRX // BETA —
CCEL // BETA —